Page last updated: 2024-10-29

ketorolac and Invasiveness, Neoplasm

ketorolac has been researched along with Invasiveness, Neoplasm in 2 studies

Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.
5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hennig, R1
Albawardi, A1
Almarzooqi, S1
Haneefa, S1
Imbaraj, E1
Zaaba, NE1
Nemmar, A1
Subramanya, S1
Maruta, H1
Adrian, TE1
Guo, Y1
Kenney, SR1
Muller, CY1
Adams, S1
Rutledge, T1
Romero, E1
Murray-Krezan, C1
Prekeris, R1
Sklar, LA1
Hudson, LG1
Wandinger-Ness, A1

Other Studies

2 other studies available for ketorolac and Invasiveness, Neoplasm

ArticleYear
1,2,3-Triazolyl ester of ketorolac (15K), a potent PAK1 blocker, inhibits both growth and metastasis of orthotopic human pancreatic cancer xenografts in mice.
    Drug discoveries & therapeutics, 2019, Nov-14, Volume: 13, Issue:5

    Topics: Animals; Body Weight; Cell Line, Tumor; Cell Proliferation; Esters; Hemodynamics; Humans; Inhibitory

2019
R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

    Topics: Allosteric Regulation; Aminoquinolines; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; cdc42

2015